Type 2 Diabetes
Joslin launches trial to explore if anti-inflammatory drug can improve glucose control
Published in Diabetes Week, February 12th, 2007
If successful, the trial could lead one day to an inexpensive way to treat this most common form of diabetes, which has been increasing at epidemic rates in recent years.
About 800 adults with poorly controlled blood glucose levels are being sought to participate in the 3-year study, referred to as Targeting Inflammation...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
Source: Diabetes Week (2007-02-12)
More Articles from Diabetes Week
- Drug Development
Insulin sensitizer MBX-102/JNJ-39659100 reduces inflammation in preclinical diabetes models - Atherosclerosis Risk Factors
Study results from Johns Hopkins University, Department of Epidemiology in the area of atherosclerosis risk factors published - Depression Risk Factors
Reports from Norwegian University of Science and Technology advance knowledge in depression risk factors - Depression Therapy
Researchers from University of Louisville discuss findings in depression therapy - Diabetic Retinopathy Cell Biology
Studies from King's College London yield new data on diabetic retinopathy cell biology - Gene Therapy
New gene therapy study findings have been reported by researchers at Genzyme Corporation, Department of Molecular Biology - More from this issue of Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
